A suspension of 1 × 106 BMSCs at passage 3 was stained with fluorescently labelled antibodies for marking and detection by flow cytometry. The following antibodies were used: CD45-APC (BioLegend), CD44-PB (BioLegend), and CD29-PE/Cy7 (BioLegend).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.